Day: December 6, 2017

Ticagrelor pharmacogenetics: Low levels of evidence

Ticagrelor (Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor used after a heart attack to prevent clots from forming and causing further heart attacks. At this moment, there no clear evidence for the use of pharmacogenetics for ticagrelor. PharmGKB, a…

Read More

TreatGx: Precision Prescribing Software

TreatGx is a precision prescribing software (medication decision support system) that personalizes prescriptions to help reduce the risk of adverse drug reactions, increase medication efficacy and reduce healthcare costs. TreatGx goes beyond the individual’s genetic code and enables precision prescribing by…

Read More

PharmGKB: Pharmacogenetic Database

PharmGKB is a publicly available internet research tool that provides information about how genetic variation among individuals contributes to differences in reactions to drugs. Developed by Stanford University and funded by the National Institutes of Health (NIH), PharmGKB is the largest…

Read More